Abhimanyu Uberoi is a Cardiology physician. OpenAlex indexes 40 publications with 1,391 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
10100 SE Sunnyside Rd
Clackamas, OR 970158970
Telephone
800-813-2000Provider last certified this registry record 28 Apr 2025.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year202519 payments
- Edwards Lifesciences CorporationProgram year202584 payments
- Abbott LaboratoriesProgram year202549 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
59%Beta blocker16.1%Metoprolol Succinate33%Metoprolol Tartrate31%Carvedilol27%Sotalol10%Part D<11 patientsStatin9.8%Atorvastatin Calcium65%Rosuvastatin Calcium35%Part D<11 patients+ 9 more classes in this area
Blood & clotting
33.5%P2Y12 inhibitor23.5%Clopidogrel90%Prasugrel Hcl10%Part D<11 patientsDirect thrombin inhibitors10%Pradaxa100%Part D≥27 patientsMetabolism & gastrointestinal
7.5%SGLT2 inhibitor7.5%Jardiance100%Part D≥23 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The Stanford Legacy and the Future of Electrocardiographic Screening of Athletes
Medical Research Archives
2024 - The Stanford Legacy and the Future of Electrocardiographic Screening of Athletes
Medical Research Archives
2024 - TCT-615 Percutaneous Coronary Intervention for Patients with Ischemic Cardiomyopathy Is Associated with Low Mortality and Improves Ejection Fraction: A Meta-Analysis of 3,844 Patients
Journal of the American College of Cardiology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”